敷尔佳 (301371)

Harbin Fuerjia Technology Co., Ltd.

ASZ

Tags

Nicotinamide Mononucleotide (NMN) ConceptChemical Raw Materials and Products ManufacturingImminent Lock-up ExpirationSynthetic BiologyDouyin (TikTok) ConceptNew RetailBelow IPO PriceHigh-Performing StocksInternet Celebrity EconomyConcentrated ShareholdingMargin Trading and Securities LendingChiNext 200 IndexChiNext 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 52010.40
  • Circulating A-Shares(W): 7752.94
  • Earnings Per Share(RMB): 0.6250
  • Net Assets Per Share(RMB): 10.7427
  • Operating Revenue(W RMB): 129715.18
  • Total Profit(W RMB): 43119.46
  • Net Profit Attributable to Parent(W RMB): 32504.38
  • Net Profit Growth Rate(%): -36.73
  • Weighted Return on Equity(%): 5.7600
  • Operating Cash Flow Per Share(RMB): 0.4680
  • Undistributed Profit Per Share(RMB): 4.2441
  • Capital Reserve Per Share(RMB): 5.1140

2. Main Business

The main business covers:

  • Research, development, production, and sales of professional skin care products.

3. Company Basic Information

  • Company Name: Harbin Fuerjia Technology Co., Ltd.
  • Listing Date: 2023-08-01
  • Industry: Manufacturing of Chemical Raw Materials and Chemical Products
  • Address: No. 500 Meigu Road, Songbei District, Harbin City, Heilongjiang Province
  • Website: www.voolga.net
  • Company Profile: The issuer was established as a joint stock company through the overall restructuring of Fuerjia Co., Ltd. On March 11, 2021, Fuerjia Co., Ltd. held a shareholders' meeting and agreed to restructure Fuerjia Co., Ltd. into a joint stock company. On March 26, 2021, all shareholders of Fuerjia Co., Ltd. held the inaugural meeting and jointly signed the "Sponsor Agreement" as sponsors. According to the "Audit Report" issued by Dahua (Dahua Audit No. [2021]003545), the audited net assets of Fuerjia Co., Ltd. as of February 28, 2021, were RMB 1,232,909,800, which were converted into Fuerjia's share capital of 360,000,000 shares at a ratio of 3.4247:1, with a par value of RMB 1 per share. The portion of net assets exceeding the share capital was included in capital reserve. According to the "Asset Appraisal Report" issued by Zhongrui Shilian (Zhongrui Appraisal Report No. [2021]000290), the book value of net assets of Fuerjia Co., Ltd. as of February 28, 2021, was RMB 1,232,909,800, and the appraised value was RMB 1,357,782,900. On March 26, 2021, Dahua issued the "Capital Verification Report" (Dahua Verification No. [2021]000172), confirming that Fuerjia had received the net assets subscribed by all sponsors, and the aforementioned net assets were converted into a total share capital of 360,000,000 shares for Fuerjia. On March 29, 2021, Fuerjia obtained the "Business License" reissued and approved by the Harbin Songbei District Market Supervision and Administration Bureau. Unified Social Credit Code: 91230103MA1AUWH313.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Harbin Sanlian Pharmaceutical Co., Ltd. General Legal Person 2340.00 30.18
2 Huabao CSI Medical ETF Fund 223.11 2.88
3 Southern CSI 1000 ETF Fund 71.13 0.92
4 GF CSI Pension Industry Index Fund A Class Fund 65.52 0.85
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 46.28 0.60
6 ChinaAMC CSI 1000 ETF Fund 42.40 0.55
7 Minsheng Jiayin CSI 2000 Index Enhanced Fund A Class Fund 4.43 0.06

5. Concept Sectors

  • New Retail
  • Internet Celebrity Economy
  • Douyin Concept
  • NMN Concept
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Imminent Share Unlock
  • High-Performance Stock
  • Below IPO Price
  • Concentrated Ownership
  • ChiNext 300
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information